BEAM News and Press, Beam Therapeutics Inc.

2026-03-02 07:18:49 ET More on ARK Invest Tracking Cathie Wood's ARK Invest 13F Portfolio - Q4 2025 Update AI Can't Sustain This Rate Of Return ARKG: Cathie Wood's Biotech Product Is In Rally Mode As Block rallies, just 3 fintech stocks hold A-rated momentum ...

2026-02-27 09:40:41 ET Company Background Beam Therapeutics Inc. ( BEAM ) was founded by David Liu, J. Keith Joung, and Feng Zhang in 2017. Its headquarters and research hub are in Cambridge, MA, while its manufacturing hub is in Durham, NC. It is one of several gene-edi...

2026-02-24 16:57:55 ET Beam Therapeutics Inc. (BEAM) Q4 2025 Earnings Call February 24, 2026 8:00 AM EST... Read the full article on Seeking Alpha For further details see: Beam Therapeutics Inc. (BEAM) Q4 2025 Earnings Call Transcript

2026-02-24 07:27:07 ET More on Beam Therapeutics Beam Therapeutics Inc. (BEAM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Beam Therapeutics: Pivoting From Platform To Execution Stage Beam Therapeutics: Strong Buy On BEAM-101 Progress And In ...

New Program Designed as Platform-based Approach for Direct Correction of Mutations Causing PKU; Investigational New Drug (IND) Filing for BEAM‑304 Anticipated in 2026 Updated Phase 1/2 Data and Next Steps for Pivotal Development for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) on ...

$100 Million Funded at Close with up to an Additional $400 Million Available Under Facility with Seven-Year Term Financing Bolsters Balance Sheet with Long-term, Non-dilutive Capital to Support Anticipated Launch of Risto-cel in Sickle Cell Disease (SCD) CAMBRIGE, Mass., Feb. 24, 2026 (GLO...

Interface Inc. (TILE) is expected to report $0.4 for Q4 2025 Evolent Health Inc Class A (EVH) is expected to report $-0.03 for Q4 2025 MercadoLibre Inc. (MELI) is expected to report $11.77 for Q4 2025 Clean Energy Fuels Corp. (CLNE) is expected to report $-0.1 for Q4 2025 Kiniksa ...

CAMBRIDGE, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will announce its fourth quarter and full year 2025 financial results and a new liver-...

2026-02-16 07:40:00 ET Cathie Wood’s ARK Invest ETFs continued a similar trend from the last week, rotating further into crypto-linked platforms, fintech, and gene-editing names while trimming exposure to software, digital advertising, and consumer internet names.... Read t...

2026-02-12 22:37:04 ET This article is part of a series that provides an ongoing analysis of the changes made to ARK Invest’ 13F portfolio on a quarterly basis. It is based on their regulatory 13F Form filed on 02/11/2026.... Read the full article on Seeking Alpha ...